Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
- 1 December 2017
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 63, 85-89
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNetBlood, 2013
- Reproducibility of the World Health Organization 2008 criteria for myelodysplastic syndromesHaematologica, 2012
- Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007Blood, 2012
- The significance of isolated Y chromosome loss in bone marrow metaphase cells from males over age 50 yearsLeukemia Research, 2011
- The changing prevalence of comorbidity across the age spectrumCritical Reviews in Oncology/Hematology, 2008
- Myelodysplastic syndromesBlood, 2008
- New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsBlood, 2007
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Sex chromosome aneuploidy and agingMutation Research/DNAging, 1995
- X and Y chromosome loss as sole abnormality in acute non-lymphocytic leukemia (ANLL)Cancer Genetics and Cytogenetics, 1994